Akifumi Kushiyama

Akifumi Kushiyama

Gifu Pharmaceutical University - Gifu / Japan
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4319161
岐阜薬科大学
person_outline Akifumi Kushiyama's MOST POPULAR ARTICLES
1-) AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3β and thereby reduces cAMP-responsive element transcriptional activity and …N Horike, H Sakoda, A Kushiyama, H Ono, M Fujishiro, H Kamata, ...Journal of Biological Chemistry 283 (49), 33902-33910, 20081982008
2-) Oxidative stress induces insulin resistance by activating the nuclear factor-κB pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinaseT Ogihara, T Asano, H Katagiri, H Sakoda, M Anai, N Shojima, H Ono, ...Diabetologia 47, 794-805, 20041982004
3-) Role of uric acid metabolism‐related inflammation in the pathogenesis of metabolic syndrome components such as atherosclerosis and nonalcoholic steatohepatitisA Kushiyama, Y Nakatsu, Y Matsunaga, T Yamamotoya, K Mori, K Ueda, ...Mediators of inflammation 2016 (1), 8603164, 20161522016
4-) Xanthine oxidoreductase is involved in macrophage foam cell formation and atherosclerosis developmentA Kushiyama, H Okubo, H Sakoda, T Kikuchi, M Fujishiro, H Sato, ...Arteriosclerosis, thrombosis, and vascular biology 32 (2), 291-298, 20121482012
5-) Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitusS Qiang, Y Nakatsu, Y Seno, M Fujishiro, H Sakoda, A Kushiyama, K Mori, ...Diabetology & metabolic syndrome 7, 1-7, 20151312015